Searching for prognostic variables for secondary worsening after ischaemic stroke.
Secondary worsening of stroke symptoms is described in 13-37% of stroke patients, but the exact mechanism of this phenomenon remains unclear. The aim of this study is to find prognostic variables in correlation to secondary worsening of stroke symptoms in patients with lacunar or cortical strokes. In this prospective observational study we included all patients with ischaemic stroke; patients with transient ischaemic attack were excluded. Patients undergoing thrombolysis and becoming symptom-free after 24 h were still included in our analyses. Secondary worsening of stroke symptoms was defined as an increase of two or more points on the NIH Stroke Scale (NIHSS). The NIHSS score was assessed on admission, at discharge, and when patients had symptoms that indicated worsening of stroke. Applying univariate and multivariable analysis, we studied the relation between symptoms indicating secondary worsening of stroke and prognostic variables such as extreme nocturnal blood pressure falls (>20% of the average blood pressure), infection, diabetes mellitus, hypertension, smoking, dyslipidaemia, a history of cardiovascular or cerebrovascular disease and thrombolysis. This study included 202 patients with a mean age of 72 years, 48.8% were men and 43% had a lacunar stroke. Secondary worsening of stroke symptoms occurred in 13.5% of all patients, more often but not significantly (NS) after lacunar than cortical strokes (16.8 and 11.4%, respectively), and in patients with extreme nocturnal blood pressure falls versus without (15.6 and 11.8%, respectively (NS)). There was no significant relation between the analysed prognostic variables and secondary worsening of stroke symptoms. This study did not show significant correlation between several variables and secondary worsening of stroke symptoms in patients with recent ischaemic stroke.
Schweitzer
Joey R
JR
Department of Neurology, Atrium Medical Centre Parkstad, Heerlen, The Netherlands.
Koehler
Peter J
PJ
Voogd
Adri C
AC
Franke
Cees L
CL
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002545:Brain Ischemia / Q000175:diagnosis* / Q000188:drug therapy; D004185:Disability Evaluation; D018450:Disease Progression; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012720:Severity of Illness Index; D020521:Stroke / Q000175:diagnosis* / Q000188:drug therapy
Arch Neurol. 2005 Mar;62(3):393-7
15767504
Cerebrovasc Dis. 2006;21(1-2):42-6
16282689
Sleep. 2005 Feb;28(2):233-8
16171248
Cerebrovasc Dis. 2006;21 Suppl 2:80-8
16651818
Hypertension. 2001 Oct;38(4):852-7
11641298
Int J Clin Pract. 2005 Nov;59(11):1272-5
16236079
Stroke. 2007 Sep;38(9):2536-40
17690313
Hypertension. 2006 Jun;47(6):e26; author reply e27
16606802
Stroke. 2005 Nov;36(11):2446-9
16224093
Hypertension. 2006 Feb;47(2):149-54
16380533
Stroke. 2002 Jun;33(6):1443-5
12052964
Arch Neurol. 1998 May;55(5):683-8
9605725
Blood Press Monit. 2006 Oct;11(5):235-41
16932032
Arq Neuropsiquiatr. 2006 Sep;64(3A):690-7
17119821
Lancet Neurol. 2008 Apr;7(4):341-53
18339349
Stroke. 2000 Apr;31(4):858-62
10753988
J Neurol Neurosurg Psychiatry. 2005 May;76(5):617-9
15834013
Int J Stroke. 2009 Aug;4(4):257-61
19689751
Stroke. 2002 Jun;33(6):1510-6
12052983